Scar Prevention Using Fractional Carbon Dioxide Laser Treatment

Inclusion Criteria: * Male or Females * At least 18 and no more than 65 years old * The surgical area closure in these subjects should be at least 4cm * Type of surgery scheduled: Site 1: Surgical area closure on thin skin, including areas that require motion (e.g. face, hands, arms, thorax, etc.) Site 2: Surgical area closure on thick skin (abdominoplasty procedure) * Willing to comply with study dosing and complete the entire course of the study Exclusion Criteria: * Active bacterial, fungal, or viral infection in the treatment area * Active cold sores, or herpes in the treatment area * Recent excessive exposure to sunlight or artificial UV light (e.g.: use of tanning beds/booths and/or sunbathing) or expectations of tanning during the time of the study * History of skin cancer, unless the surgical procedure of issue is for cancer treatment purposes. * History of or the presence of any skin condition/disease that might interfere with the diagnosis or evaluation of study parameters (i.e., atopic dermatitis, eczema, psoriasis) * Treatment with a systemic retinoid within the past year (e.g., Accutane®, Roche Dermatologics) * History or presenting with a keloid scar * Any current or recent treatment for cancer, unless the surgical procedure of issue is for cancer treatment purposes. * Any uncontrolled systemic disease. A potential subject in whom therapy for a systemic disease is not yet stabilized will not be considered for entry into the study * Significant history or current evidence of a medical, psychological or other disorder that, in the investigator's opinion, would preclude enrollment into the study. * Subject planning any other cosmetic procedure to the study area during the study period, other than the treatments that will be performed by the investigator * Female subject who is pregnant, nursing an infant or is less than 6 months after termination of breast feeding * Small surgical closure (\<4cm)